featured
Guide to Dose Optimization of Secukinumab in Patients With Chronic Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical and Experimental Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis
Clin Exp Dermatol 2022 Mar 04;[EPub Ahead of Print], R Soenen, Z Wang, L Grine, E Dreesen, L Schots, E Brouwers, P Declerck, D Thomas, J LambertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.